ABBEY CHI: Open Payments
NPI 1326689290 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 33 payments from 14 companies in 2025. Trend: 2023 $829 · 2024 $706 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $149 |
| Novo Nordisk Inc | 4 | $81 |
| Exact Sciences Corporation | 4 | $66 |
| Amgen Inc. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
Products named: VRAYLAR, Cologuard Collection Kit, REXULTI, Ozempic, VOQUEZNA, OTEZLA, AIRSUPRA, LifeVest.
Industry payments across PA — which companies pay providers there.
